- Home
- OTLK vs SND Comparison
OTLK vs SND Comparison
Compare OTLK & SND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OTLK | SND |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | United States |
| Employees | 17 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.3M | 99.3M |
| IPO Year | 2016 | 2016 |
Fundamental Metrics
Financial Performance| Metric | OTLK | SND |
|---|---|---|
| Price | $0.56 | $4.16 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 8.1M | 528.7K |
| Earning Date | 02-13-2026 | 11-12-2025 |
| Dividend Yield | N/A | ★ 3.71% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | $1,413,535.00 | ★ $335,471,000.00 |
| Revenue This Year | $2,048.59 | N/A |
| Revenue Next Year | $142.11 | N/A |
| P/E Ratio | ★ N/A | $40.45 |
| Revenue Growth | N/A | ★ 18.98 |
| 52 Week Low | $0.60 | $1.76 |
| 52 Week High | $3.39 | $4.51 |
Technical Indicators
Market Signals| Indicator | OTLK | SND |
|---|---|---|
| Relative Strength Index (RSI) | 22.80 | 62.33 |
| Support Level | $1.78 | $3.68 |
| Resistance Level | $2.03 | $4.07 |
| Average True Range (ATR) | 0.25 | 0.28 |
| MACD | -0.17 | -0.02 |
| Stochastic Oscillator | 2.64 | 88.45 |
Price Performance
Historical ComparisonAbout OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About SND Smart Sand Inc.
Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.